These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26934856)

  • 1. The human ovarian cancer cell line CABA I: A peculiar genetic evolution.
    Giusti I; Cervelli C; D'Ascenzo S; Di Francesco M; Ligas C; D'Alessandro E; Papola F; Dolo V
    Int J Mol Med; 2016 Apr; 37(4):879-88. PubMed ID: 26934856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of STR profiles in ovarian carcinoma cells during primary culture.
    Huang X; Weimer J; von Wurmb-Schwark N; Fredrik R; Arnold N; Schem C
    Arch Gynecol Obstet; 2016 Aug; 294(2):369-76. PubMed ID: 26825732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal chromosomal and genomic instability during human multipotent mesenchymal stromal cells long-term culture.
    Nikitina V; Astrelina T; Nugis V; Ostashkin A; Karaseva T; Dobrovolskaya E; Usupzhanova D; Suchkova Y; Lomonosova E; Rodin S; Brunchukov V; Lauk-Dubitskiy S; Brumberg V; Machova A; Kobzeva I; Bushmanov A; Samoilov A
    PLoS One; 2018; 13(2):e0192445. PubMed ID: 29432491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural and phenotypic characterization of CABA I, a new human ovarian cancer cell line.
    Dolo V; Ginestra A; Violini S; Miotti S; Festuccia C; Miceli D; Migliavacca M; Rinaudo C; Romano FM; Brisdelli F; Canevari S; Pavan A; Vittorelli ML
    Oncol Res; 1997; 9(3):129-38. PubMed ID: 9220498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.
    Korch C; Spillman MA; Jackson TA; Jacobsen BM; Murphy SK; Lessey BA; Jordan VC; Bradford AP
    Gynecol Oncol; 2012 Oct; 127(1):241-8. PubMed ID: 22710073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the cytogenetic stability of the human embryonal kidney cell line 293 by cytogenetic and STR profiling approaches.
    Bylund L; Kytölä S; Lui WO; Larsson C; Weber G
    Cytogenet Genome Res; 2004; 106(1):28-32. PubMed ID: 15218237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells.
    Prinetti A; Millimaggi D; D'Ascenzo S; Clarkson M; Bettiga A; Chigorno V; Sonnino S; Pavan A; Dolo V
    Biochem J; 2006 Apr; 395(2):311-8. PubMed ID: 16356169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and molecular cytogenetic characterization of the stable ovarian carcinoma cell line (OvBH-1).
    Schlade-Bartusiak K; Sasiadek MM; Bar JK; Urbschat S; Blin N; Montenarh M; Harłozińska-Szmyrka A
    Cancer Genet Cytogenet; 2006 Jan; 164(1):10-5. PubMed ID: 16364757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a multifactorial resistance phenotype by high paclitaxel selective pressure in a human ovarian carcinoma cell line.
    Violini S; D'Ascenzo S; Bagnoli M ; Millimaggi D; Miotti S; Canevari S; Pavan A; Dolo V
    J Exp Clin Cancer Res; 2004 Mar; 23(1):83-91. PubMed ID: 15149155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.
    Bayani J; Brenton JD; Macgregor PF; Beheshti B; Albert M; Nallainathan D; Karaskova J; Rosen B; Murphy J; Laframboise S; Zanke B; Squire JA
    Cancer Res; 2002 Jun; 62(12):3466-76. PubMed ID: 12067990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Match criteria for human cell line authentication: where do we draw the line?
    Capes-Davis A; Reid YA; Kline MC; Storts DR; Strauss E; Dirks WG; Drexler HG; MacLeod RA; Sykes G; Kohara A; Nakamura Y; Elmore E; Nims RW; Alston-Roberts C; Barallon R; Los GV; Nardone RM; Price PJ; Steuer A; Thomson J; Masters JR; Kerrigan L
    Int J Cancer; 2013 Jun; 132(11):2510-9. PubMed ID: 23136038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential cytogenetic studies in an ovarian cancer cell line.
    Smith A; van Haaften-Day C; Russell P
    Cancer Genet Cytogenet; 1989 Mar; 38(1):13-24. PubMed ID: 2713809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human ovarian teratocarcinoma cell line PA-1 demonstrates a single translocation: analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray.
    Sarraf S; Tejada R; Abawi M; Oberst M; Dennis T; Simon KC; Blancato J
    Cancer Genet Cytogenet; 2005 Aug; 161(1):63-9. PubMed ID: 16080959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling and authentication of human cell lines using short tandem repeat (STR) loci: Report from the National Cell Bank of Iran.
    Azari S; Ahmadi N; Tehrani MJ; Shokri F
    Biologicals; 2007 Jun; 35(3):195-202. PubMed ID: 17254797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLASTR: The Cellosaurus STR similarity search tool - A precious help for cell line authentication.
    Robin T; Capes-Davis A; Bairoch A
    Int J Cancer; 2020 Mar; 146(5):1299-1306. PubMed ID: 31444973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification.
    Nims RW; Sykes G; Cottrill K; Ikonomi P; Elmore E
    In Vitro Cell Dev Biol Anim; 2010 Dec; 46(10):811-9. PubMed ID: 20927602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer?
    Panani AD
    Cancer Lett; 2007 Dec; 258(2):262-7. PubMed ID: 17945413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic heterogeneity and their serial dynamic changes during acquisition of cytogenetic aberrations in cultured mesenchymal stem cells.
    Kim JA; Im KO; Park SN; Kwon JS; Kim SY; Oh K; Lee DS; Kim MK; Kim SW; Jang M; Lee G; Oh YM; Lee SD; Lee DS
    Mutat Res; 2015 Jul; 777():60-8. PubMed ID: 25974687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.